RAB27A and neoplasm: The volume of tumors formed by the co-injection of Rab27a (−) cells was slightly lower than that by Rab27a (+) LM.4T1 cells on day 28 (Fig. 4E), but there was no difference in tumor weight (Fig. 4F).